Drug
CD4 Immunoadhesins clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
How studies write it
Studies that test it under each name
Name
- CD4-IgG
- 6
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 5
National Institute of Allergy and Infectious Diseases (NIAID) (5) · Genentech, Inc. (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Immunologic Factors source
Studies
Open first, then newest update. How each study uses CD4 Immunoadhesins is read from its arms, and is right about nine times in ten.
Testing it · 6
- An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV InfectionCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000647Written as CD4-IgG
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related ComplexCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000976Written as CD4-IgG
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 InfectionCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000663Written as CD4-IgG
- A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic PurpuraCompletedPhase 1Genentech, Inc.NCT00002250Written as CD4-IgG
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their NewbornsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000642Written as CD4-IgG
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related ComplexCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000675Written as CD4-IgG
Codes
What other systems call CD4 Immunoadhesins · ClinicalTrials.gg INT008549
- MeSH (NLM) D016860CD4 ImmunoadhesinsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D016860 | CD4 Immunoadhesins | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.